...Done!
Skip to main content
🔍 See what insiders are buying — free 7-day trial, no credit card required. Get started →
LH NYSE 🇺🇸 US
Labcorp
Healthcare
Not a Dip
Price Zone: Hold / Watch
🔒 Full AI Analysis — Pro
20Score
DipBuster Score™
$306.96 $14.14 (-4.4%) Live price · Source: Yahoo
52-Week Position
$244.52 64% of range $341.80
Dividend
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
BetaN/A
52W High$341.80
52W Low$244.52
DipBuster Brief Key signals at a glance
Zone: Hold / Watch
Neutral
Mid-Range Position (64% of 52-Week Range)
The stock sits in the middle of its annual range — no extreme dip opportunity, but also not overextended.
Neutral
Earnings Data Unavailable
P/E ratio could not be determined — this is common for early-stage, loss-making, or recently-listed companies.
Valuation
P/E Ratio
Mkt CapN/A
52W Position64% of range
EV/EBITDA
Cash Flow
FCF Yield
FCF / Share
Op. Cash Flow
Margins
Gross Margin
Op. Margin
Net Margin
Balance Sheet
Cash
Total Debt
Net Cash
Dividend
Yield
Annual / shNone
Beta
🔒 FCF, margins & balance sheet data are hidden — create a free account to see them.
Charts

Recent director dealings and insider transactions at Labcorp (LH), from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.

Date Insider Type Shares
2026-08-11 Schechter Adam H SELL 4,669
2026-08-04 Summy Amy B. SELL 924
2026-08-03 Wilkinson Peter J SELL 1,338
2026-08-03 Wilkinson Peter J SELL 1,338
2026-08-03 Wilkinson Peter J BUY 1,338
2026-08-03 Wilkinson Peter J SELL 82
2026-07-02 Vaughn Bryan T SELL 234
2026-07-02 Kyle Kathryn W SELL 92
2026-07-01 Vaughn Bryan T SELL 327
2026-07-01 Vaughn Bryan T SELL 93

Valuation

P/E RatioN/A
Market CapN/A
BetaN/A
Dividend/yrNone
52W High$341.80
52W Low$244.52

52-Week Range

$244.52Now$341.80
64% through annual range
From 52W High−10.2%
From 52W Low+25.5%
📖 Plain English Summary
Labcorp is at 64% of its 52-week range.

🏦 Analyst Price Target

Loading…

🎯 Analyst Revenue & EPS Estimates

Loading estimates…

🔄 Peer Comparison

Loading peers…
Loading dividend data…
Latest news for LH 🟢 Bullish ⬜ Neutral 🔴 Bearish
🤖
DipBuster AI Analysis — LH
Heuristic · balance sheet, insider filings, price data, academic research

Labcorp — DipBuster Score 20/100

Graham value assessment, NCAV analysis, price zones...

Insider signals, cluster detection, risk factors...

🔒
Full AI Analysis — Pro
Price zones, Graham analysis, insider signals
Upgrade →

Track Labcorp free

Add LH to a watchlist, set insider-buy and price alerts, and get the full financial picture — free account, no card.

Sponsored · FCA Regulated Broker
Trading 212
Commission-free investing. ISA and GIA available. FCA regulated.
Free share worth up to £100 when you sign up
Open Free Account →
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E 0/30
Dip Position 14/25
Momentum & Volume 1/25
Quality & Size 5/10
Insider Activity 0/10
🎯 Dip Buyer Signal
27 /100 · NEUTRAL
dip depth 1/25
oversold rsi 11/25
mean reversion 15/15
insider zone 0/25
capitulation 0/10
Technical signal only. Not financial advice.
Quick Take
Not a Dip
DipBuster Score: 20/100
📉 Weak momentum — price has been struggling lately.

More Healthcare stocks

UNH UnitedHealth GroupJNJ Johnson & JohnsonABT Abbott LaboratoriesTMO Thermo Fisher ScientificDHR Danaher Corp.MDT Medtronic plcSYK Stryker Corp.BSX Boston ScientificAll Healthcare stocks →